Effectiveness of home-centered care through telemedicine applications for overweight and obese patients

A randomized controlled trial

D. G. Goulis, G. D. Giaglis, S. A. Boren, I. Lekka, E. Bontis, E Andrew Balas, N. Maglaveras, A. Avramides

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

OBJECTIVE: To determine if home-centered monitoring through telemedicine has an impact on clinical characteristics, metabolic profile and quality of life in overweight and obese patients. DESIGN: Randomized controlled trial, 6-month duration. SETTING: Tertiary care academic hospital. SUBJECTS: A total of 122 patients were eligible to participate as they met the inclusion criteria of increased body mass index (BMI > 25kg/m2), age > 18 and < 70 y and ability to operate electronic microdevices. INTERVENTIONS: All patients in the control group (n = 77) received standard hospital care. Patients in the intervention group (n = 45), additionally, measured three times a week, for 6 months, their blood pressure and body weight and transmitted them to an automated call center. These values were not shared with the patients' physician or dietician. MAIN OUTCOME MEASURES: Clinical (body weight, BMI, blood pressure), laboratory (fasting plasma glucose, triglycerides, HDL-cholesterol, total cholesterol) and quality of life parameters (SF-36®, Visual Analog Scale of European Quality-5 Dimensions, Obesity Assessment Survey). Data were analyzed in an intention-to-treat-way (last observation carried forward). RESULTS: Drop-out rate was similar in the control and intervention groups: 12 vs 11 percent, respectively, P = NS. There were no significant differences at baseline between intervention and control groups in all main outcome parameters. There were significant decreases for patients in the intervention group in body weight (from 101.6 ± 22.4 to 89.2 ± 14.7 kg, P = 0.002, P = 0.05 vs controls at 6 months), total cholesterol (from 247.6 ± 42.0 to 220.7 ± 42.6 mg/dl, P = 0.002, P = 0.05 vs controls at6 months) and triglycerides (from 148.4 ± 35.0 to 122.3 ± 31.4 mg/dl, P = 0.001, P = 0.01 vs controls at 6 months). Intervention group patients made a total of 1997 phone contacts. The number of phone contacts was correlated positively with Social Functioning (SF), Vitality (VT) and Mental Health (MH) scores of SF-36® at baseline (r = 0.48, r = 0.41, r = 0.41, respectively, P = 0.05) but not with weight loss. CONCLUSIONS: Home-centered, intense treatment through the use of telemedicine can be effective in improving short-term obesity outcomes.

Original languageEnglish (US)
Pages (from-to)1391-1398
Number of pages8
JournalInternational Journal of Obesity
Volume28
Issue number11
DOIs
StatePublished - Nov 1 2004

Fingerprint

Telemedicine
Home Care Services
Randomized Controlled Trials
Body Weight
Control Groups
Triglycerides
Obesity
Cholesterol
Quality of Life
Blood Pressure
Aptitude
Metabolome
Nutritionists
Tertiary Healthcare
Visual Analog Scale
HDL Cholesterol
Weight Loss
Fasting
Mental Health
Body Mass Index

Keywords

  • Follow-up
  • Management
  • Quality of life
  • Telemedicine

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Effectiveness of home-centered care through telemedicine applications for overweight and obese patients : A randomized controlled trial. / Goulis, D. G.; Giaglis, G. D.; Boren, S. A.; Lekka, I.; Bontis, E.; Balas, E Andrew; Maglaveras, N.; Avramides, A.

In: International Journal of Obesity, Vol. 28, No. 11, 01.11.2004, p. 1391-1398.

Research output: Contribution to journalArticle

Goulis, D. G. ; Giaglis, G. D. ; Boren, S. A. ; Lekka, I. ; Bontis, E. ; Balas, E Andrew ; Maglaveras, N. ; Avramides, A. / Effectiveness of home-centered care through telemedicine applications for overweight and obese patients : A randomized controlled trial. In: International Journal of Obesity. 2004 ; Vol. 28, No. 11. pp. 1391-1398.
@article{de8b44883ce24e5f870ad20a9e129094,
title = "Effectiveness of home-centered care through telemedicine applications for overweight and obese patients: A randomized controlled trial",
abstract = "OBJECTIVE: To determine if home-centered monitoring through telemedicine has an impact on clinical characteristics, metabolic profile and quality of life in overweight and obese patients. DESIGN: Randomized controlled trial, 6-month duration. SETTING: Tertiary care academic hospital. SUBJECTS: A total of 122 patients were eligible to participate as they met the inclusion criteria of increased body mass index (BMI > 25kg/m2), age > 18 and < 70 y and ability to operate electronic microdevices. INTERVENTIONS: All patients in the control group (n = 77) received standard hospital care. Patients in the intervention group (n = 45), additionally, measured three times a week, for 6 months, their blood pressure and body weight and transmitted them to an automated call center. These values were not shared with the patients' physician or dietician. MAIN OUTCOME MEASURES: Clinical (body weight, BMI, blood pressure), laboratory (fasting plasma glucose, triglycerides, HDL-cholesterol, total cholesterol) and quality of life parameters (SF-36{\circledR}, Visual Analog Scale of European Quality-5 Dimensions, Obesity Assessment Survey). Data were analyzed in an intention-to-treat-way (last observation carried forward). RESULTS: Drop-out rate was similar in the control and intervention groups: 12 vs 11 percent, respectively, P = NS. There were no significant differences at baseline between intervention and control groups in all main outcome parameters. There were significant decreases for patients in the intervention group in body weight (from 101.6 ± 22.4 to 89.2 ± 14.7 kg, P = 0.002, P = 0.05 vs controls at 6 months), total cholesterol (from 247.6 ± 42.0 to 220.7 ± 42.6 mg/dl, P = 0.002, P = 0.05 vs controls at6 months) and triglycerides (from 148.4 ± 35.0 to 122.3 ± 31.4 mg/dl, P = 0.001, P = 0.01 vs controls at 6 months). Intervention group patients made a total of 1997 phone contacts. The number of phone contacts was correlated positively with Social Functioning (SF), Vitality (VT) and Mental Health (MH) scores of SF-36{\circledR} at baseline (r = 0.48, r = 0.41, r = 0.41, respectively, P = 0.05) but not with weight loss. CONCLUSIONS: Home-centered, intense treatment through the use of telemedicine can be effective in improving short-term obesity outcomes.",
keywords = "Follow-up, Management, Quality of life, Telemedicine",
author = "Goulis, {D. G.} and Giaglis, {G. D.} and Boren, {S. A.} and I. Lekka and E. Bontis and Balas, {E Andrew} and N. Maglaveras and A. Avramides",
year = "2004",
month = "11",
day = "1",
doi = "10.1038/sj.ijo.0802773",
language = "English (US)",
volume = "28",
pages = "1391--1398",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Effectiveness of home-centered care through telemedicine applications for overweight and obese patients

T2 - A randomized controlled trial

AU - Goulis, D. G.

AU - Giaglis, G. D.

AU - Boren, S. A.

AU - Lekka, I.

AU - Bontis, E.

AU - Balas, E Andrew

AU - Maglaveras, N.

AU - Avramides, A.

PY - 2004/11/1

Y1 - 2004/11/1

N2 - OBJECTIVE: To determine if home-centered monitoring through telemedicine has an impact on clinical characteristics, metabolic profile and quality of life in overweight and obese patients. DESIGN: Randomized controlled trial, 6-month duration. SETTING: Tertiary care academic hospital. SUBJECTS: A total of 122 patients were eligible to participate as they met the inclusion criteria of increased body mass index (BMI > 25kg/m2), age > 18 and < 70 y and ability to operate electronic microdevices. INTERVENTIONS: All patients in the control group (n = 77) received standard hospital care. Patients in the intervention group (n = 45), additionally, measured three times a week, for 6 months, their blood pressure and body weight and transmitted them to an automated call center. These values were not shared with the patients' physician or dietician. MAIN OUTCOME MEASURES: Clinical (body weight, BMI, blood pressure), laboratory (fasting plasma glucose, triglycerides, HDL-cholesterol, total cholesterol) and quality of life parameters (SF-36®, Visual Analog Scale of European Quality-5 Dimensions, Obesity Assessment Survey). Data were analyzed in an intention-to-treat-way (last observation carried forward). RESULTS: Drop-out rate was similar in the control and intervention groups: 12 vs 11 percent, respectively, P = NS. There were no significant differences at baseline between intervention and control groups in all main outcome parameters. There were significant decreases for patients in the intervention group in body weight (from 101.6 ± 22.4 to 89.2 ± 14.7 kg, P = 0.002, P = 0.05 vs controls at 6 months), total cholesterol (from 247.6 ± 42.0 to 220.7 ± 42.6 mg/dl, P = 0.002, P = 0.05 vs controls at6 months) and triglycerides (from 148.4 ± 35.0 to 122.3 ± 31.4 mg/dl, P = 0.001, P = 0.01 vs controls at 6 months). Intervention group patients made a total of 1997 phone contacts. The number of phone contacts was correlated positively with Social Functioning (SF), Vitality (VT) and Mental Health (MH) scores of SF-36® at baseline (r = 0.48, r = 0.41, r = 0.41, respectively, P = 0.05) but not with weight loss. CONCLUSIONS: Home-centered, intense treatment through the use of telemedicine can be effective in improving short-term obesity outcomes.

AB - OBJECTIVE: To determine if home-centered monitoring through telemedicine has an impact on clinical characteristics, metabolic profile and quality of life in overweight and obese patients. DESIGN: Randomized controlled trial, 6-month duration. SETTING: Tertiary care academic hospital. SUBJECTS: A total of 122 patients were eligible to participate as they met the inclusion criteria of increased body mass index (BMI > 25kg/m2), age > 18 and < 70 y and ability to operate electronic microdevices. INTERVENTIONS: All patients in the control group (n = 77) received standard hospital care. Patients in the intervention group (n = 45), additionally, measured three times a week, for 6 months, their blood pressure and body weight and transmitted them to an automated call center. These values were not shared with the patients' physician or dietician. MAIN OUTCOME MEASURES: Clinical (body weight, BMI, blood pressure), laboratory (fasting plasma glucose, triglycerides, HDL-cholesterol, total cholesterol) and quality of life parameters (SF-36®, Visual Analog Scale of European Quality-5 Dimensions, Obesity Assessment Survey). Data were analyzed in an intention-to-treat-way (last observation carried forward). RESULTS: Drop-out rate was similar in the control and intervention groups: 12 vs 11 percent, respectively, P = NS. There were no significant differences at baseline between intervention and control groups in all main outcome parameters. There were significant decreases for patients in the intervention group in body weight (from 101.6 ± 22.4 to 89.2 ± 14.7 kg, P = 0.002, P = 0.05 vs controls at 6 months), total cholesterol (from 247.6 ± 42.0 to 220.7 ± 42.6 mg/dl, P = 0.002, P = 0.05 vs controls at6 months) and triglycerides (from 148.4 ± 35.0 to 122.3 ± 31.4 mg/dl, P = 0.001, P = 0.01 vs controls at 6 months). Intervention group patients made a total of 1997 phone contacts. The number of phone contacts was correlated positively with Social Functioning (SF), Vitality (VT) and Mental Health (MH) scores of SF-36® at baseline (r = 0.48, r = 0.41, r = 0.41, respectively, P = 0.05) but not with weight loss. CONCLUSIONS: Home-centered, intense treatment through the use of telemedicine can be effective in improving short-term obesity outcomes.

KW - Follow-up

KW - Management

KW - Quality of life

KW - Telemedicine

UR - http://www.scopus.com/inward/record.url?scp=8344251725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8344251725&partnerID=8YFLogxK

U2 - 10.1038/sj.ijo.0802773

DO - 10.1038/sj.ijo.0802773

M3 - Article

VL - 28

SP - 1391

EP - 1398

JO - International Journal of Obesity

JF - International Journal of Obesity

SN - 0307-0565

IS - 11

ER -